Ratings by BTIG (Kambiz Yazdi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2026 | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
14.08 (12.26) |
-12.93% | Details | |
| 6/9/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2026 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
5.16 (7.56) |
46.51% | Details | |
| 4/14/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Zevra Therapeutics, Inc. | ZVRA | New Coverage | Buy (N/A) |
9.98 (9.53) |
-4.51% | Details | |
| 3/11/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2025 | Sionna Therapeutics | SION | New Coverage | Buy (N/A) |
39.93 (45.70) |
14.45% | Details | |
| 11/19/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
25.11 (40.68) |
62.01% | Details | |
| 11/19/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
197.58 (325.30) |
64.64% | Details | |
| 11/19/2025 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
30.15 (30.73) |
1.92% | Details |
